Integrated Filing — IndAS



General information about company

Scrip Code 523457
NSE Symbol LINDEINDIA
MSEI Symbol NOTLISTED
ISIN INE473A01011
Name of company LINDE INDIA LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 30-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 15-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 30-05-2026   13:30:00
End date and time of board meeting 30-05-2026   16:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 61,433.30 2,53,064.00
Other income 593.00 1,824.00
Total income 62,026.30 2,54,888.00
2 Expenses
(a) Cost of materials consumed 6,845.20 25,795.00
(b) Purchases of stock-in-trade 8,274.90 31,962.40
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (687.00) (1,068.20)
(d) Employee benefit expense 1,351.30 5,687.30
(e) Finance costs 265.90 1,449.80
(f) Depreciation, depletion and amortisation expense 6,077.10 23,487.00
(f) Other Expenses
1 Power and fuel 13,075.30 41,744.10
2 Other Expenses 15,283.70 58,031.60
Total other expenses 28,359.00 99,775.70
Total expenses 50,486.40 1,87,089.00
3 Total profit before exceptional items and tax 11,539.90 67,799.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 11,539.90 67,799.00
6 Tax expense
7 Current tax 2,940.60 17,768.30
8 Deferred tax 917.10 682.70
9 Total tax expenses 3,857.70 18,451.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 7,682.20 49,348.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 62.40 5,548.50
16 Total profit (loss) for period 7,744.60 54,896.50
17 Other comprehensive income net of taxes 52.80 (115.20)
18 Total Comprehensive Income for the period 7,797.40 54,781.30
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 0.00 0.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 8,528.40 8,528.40
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 4,18,126.30
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 9.08 64.37
Diluted earnings (loss) per share from continuing operations 9.08 64.37
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 9.08 64.37
Diluted earnings (loss) per share from continuing and discontinued operations 9.08 64.37
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes: (i) The financial results were reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on 29th May 2026 and 30th May 2026 . The audit for the year ended 31st March 2026, as required under Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, have been carried out by the Statutory Auditors. (ii) The Consolidated financial results reflect the results of Linde India Limited (Company) and share of profit of two Joint ventures 'Linde South Asia Services Private Limited' and ‘Bellary Oxygen Company Private Limited’ (which was reclassified from “assets held for sale” to investment in joint venture during the quarter ended 31st December 2025). Company has entered into share subscription and shareholder’s agreement (SHA) and power purchase agreements (PPA) (Collectively known as arrangement) with certain special purpose vehicle entities (SPV) namely Avaada MHYavat Private Limited, FP Solar Shakti Private Limited (till 10th September, 2025), FPEL Surya Private Limited and Zenataris Renewable Energy Private Limited to purchase renewable energy. As per the terms of SHAs, the Company is required to transfer the shares of SPV on termination / end of PPA to the promoters of SPV at the value defined in SHA. While such investments are considered as associates under Ind AS 28 considering the terms of arrangement of these investments like voting rights, contractual arrangement for offtake of power etc, the Company's investment in such entities does not provide it access to the returns associated with ownership interests. Accordingly, the Company has determined that it is not required to apply equity method of accounting for investment in these associates, and consequently, such investments are classified as investments in debt instruments and are measured at amortised cost at each reporting date. (iii) (A) Certain Shareholders have raised objections on the related party transactions entered into by Linde India Limited (Company) with Praxair India Private Limited (PIPL) and Linde South Asia Services Private Limited since the resolution on material related party transactions in the 85th AGM held on 24 June 2021 had been rejected by the shareholders. The Company has also received inquiries and information requests from the Securities and Exchange Board of India in connection with certain related party transactions and arrangements to which the Company has responded. Based on the legal opinions obtained by the Company, the Company is in compliance with all requirements under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 in respect of all related party transactions entered into by it. No related party transaction entered into by the Company has a value in excess of the materiality threshold of 10% or more of the annual consolidated turnover of the Company. Therefore, there are no material related party transactions entered into by the Company. In terms of the legal opinion obtained by the Company, it has applied the materiality threshold of 10% or more of the annual consolidated turnover of the Company to the value of each contract with a related party consisting of individual or multiple transactions and not by aggregating the value of all contracts with each related party and ascertained that no shareholder approval is required for any related party transaction in terms of Regulation 23 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, which is not material in nature. In October 2023, SEBI summoned the Managing Director and the Company Secretary of the Company to appear before its Investigating Authority (“IA”) and has also summoned the Company to furnish certain information and documents, all in connection with its investigation into financial information and business transactions of the Company. Pursuant thereto, they appeared before SEBI and also subsequently responded to the questions with information and documents. The Investigating Officer further issued summons to Independent Directors in January 2024 and sought responses to certain queries and also again sought additional documents and information from the Company. Based on legal review and advice, Writ Petitions were filed in the Hon’ble Bombay High Court (one by all the three IDs and another by the Company) seeking a quash of the aforementioned proceedings and for stay of such proceedings in the interim. While the Writ petitions were pending hearing before the Hon’ble Bombay High Court, SEBI passed an Interim Ex Parte Order on 29th April 2024, against which the Company filed an appeal before the Securities Appellate Tribunal (SAT), and Hon’ble SAT set aside the Interim Ex Parte Order vide its Order dated 22nd May 2024 and allowed the Company to inspect documents and file its reply. Subsequently, Company inspected the documents and made its submissions and thereafter SEBI passed an order dated July 24, 2024 (the “SEBI Order”) giving its conclusion and directions and also stated that the role/ culpability of the Directors/ Officers of the Company, if any, for issues covered under this Order, will also be addressed separately. The directions issued in respect of assessing materiality threshold for related party transactions are summarized below : a. The Company shall test the materiality of future RPTs as per the threshold provided under Regulation 23(1) of the SEBI LODR Regulations on the basis of the aggregate value of the transactions entered into with any related party in a financial year, irrespective of the number of transactions or contracts involved. b. In the event the aggregate value of the related party transactions, calculated as provided in clause (a), exceeds the materiality threshold provided under Regulation 23(1), the Company shall obtain approvals as mandated under Regulation 23(4) of the SEBI LODR Regulations. The Company has filed an Appeal on 5th August 2024 against the aforementioned Order of SEBI before the Securities Appellate Tribunal and after several hearings, the Hon’ble Tribunal vide its order dated 5th December 2025 dismissed the appeal filed by the Company. The Company filed an Appeal on 16th December 2025 against the Order of Hon’ble Securities Appellate Tribunal before the Hon’ble Supreme Court and upon hearing the matter on 16th January 2026, the Hon’ble Supreme Court was pleased to admit the Appeal but no stay was granted, however, it stated that before an action is taken on the valuation, Hon'ble Supreme Court shall be informed about the same. Without prejudice to the Company’s interpretation on Related Party Transactions before the SEBI, SAT and the Hon’ble Supreme Court, and as a matter of abundant caution and to protect the interest of the Company and as legally advised, the Company sought the approval of the Members of the Company by way of an ordinary resolution, as per the interpretation of SEBI on the materiality threshold of the transactions with a Related Party, at the extra-ordinary General Meeting held on 5th March 2026. Since, the proposed resolution was not passed by the Members, the Company had not carried out any related party transactions with Praxair India Private Limited for the balance period of the financial year. The Company also received further summons from SEBI dated April 9, 2026 and April 28, 2026, seeking information and data. The Company has furnished its response vide letter dated 19th May 2026. Management regularly evaluates the business and regulatory risks, including the above matters and it recognises the related uncertainties around their ultimate outcomes, the impact of which, if any, is not presently ascertainable. (iii) (B) As an integral part of the JV Agreement dated 24th March, 2020, which was duly approved by the Board of Directors of the Company on 24th March, 2020, the Company and Praxair India Private Limited (PIPL), a fellow subsidiary, agreed to have an aligned approach towards customers across India based on criteria like, proximity to existing plants of both the companies, incumbency, availability of technology, availability of plant configurations or suitable product lines, ability to offer the cheapest solution, compliance with the competition law, etc. In order to avoid conflict, new onsite air gas business with limited merchant credit is to be pursued based on factors like incumbency or technology advantage and competitiveness and new onsite air gas business with significant merchant credit is to be pursued based on geographical regions. Any expansions and/or renewals of existing business is guided by the principle of incumbency - where the entity already having an existing business relationship will get to bid for any expansions and/or renewals related to such existing business. Allocation of new merchant business between the Company and PIPL is determined on incumbency and in the absence of incumbency it is determined on geographical basis, and this has been enunciated in the JV agreement. Accordingly, the Company will handle new merchant business exclusively in Eastern India, Northern India, and Western India (excluding Industrial Bulk Business in Maharashtra) whilst PIPL will handle new merchant business in South India, Central India and in the Industrial Bulk Business in Maharashtra. Further, the project engineering business was agreed to be pursued solely by the company and the CO2 and HYCO & PST business was agreed to be pursued solely by PIPL. The allocation of business has been agreed mutually in a transparent and equitable manner and is based on sound business principles, efficiency of logistics and judgement. The Board and the Management have ensured that the Company’s legitimate business interests have been sufficiently protected and are not jeopardized due to such allocation. SEBI, vide its Order dated July 24, 2024 was of the view that (a) this business allocation, though characterized as a division of future business rather than a current transaction, effectively alters the distribution of business opportunities between the related parties; (b) such arrangements can result in a redistribution of corporate business and opportunities that would otherwise benefit the company; (c) this seemingly benign but arbitrary reallocation of business presents a potential risk to the future growth prospects of the Company, which may not serve the best interests of the public shareholders. In SEBI’s view, transactions of this nature must be subjected to rigorous scrutiny and require approvals akin to traditional RPTs to ensure that investor interests are safeguarded. It also held that the business allocation between the Company and PIPL prima facie constitutes a transfer of resources by a listed company to a related party and that this transfer should have been preceded by a valuation exercise or financial impact analysis to enable the Board of the Company to make an informed decision. The directions issued in respect of JV agreement and allocation of business between the Company and PIPL are summarized below: a. NSE shall appoint a registered valuer to carry out a valuation of the business foregone and received, including by way of geographic allocation, in terms of Annexure IV of the JV&SHA. b. NSE shall share the valuation report received from the valuer appointed in compliance with the directions contained in this Order with the Company and SEBI. c. The Company shall within two weeks of receiving the valuation report place it before the Audit Committee and the Board. d. The Company shall make a disclosure on the stock exchanges providing a summary of the key observations in the valuation report along with management comments on the same. SEBI, in its order dated July 24, 2024, has also stated that in respect of the allegations concerning the business allocation under the JV&SHA, further course of action will be determined post receipt of the valuation report and that the role/ culpability of the Directors/ Officers of the Company, if any, for issues covered under this Order, will also be addressed separately. The Company has filed an Appeal on 5th August 2024 against the aforementioned Order of SEBI before the Securities Appellate Tribunal and after several hearings, the Hon’ble Tribunal vide its order dated 5th December 2025 dismissed the appeal filed by the Company. The Company filed an Appeal on 16th December 2025 against the Order of Hon’ble Securities Appellate Tribunal before the Hon’ble Supreme Court and upon hearing the matter on 16th January 2026, the Hon’ble Supreme Court was pleased to admit the Appeal but no stay was granted, however, it stated that before an action is taken on the valuation, Hon'ble Supreme Court shall be informed about the same. The Company had on 24th March 2026 received a Valuation Report dated 16th March 2026 from The National Stock Exchange of India Limited (NSE) and the NSE directed the Company to place the Valuation Report within two weeks of the receipt thereof before the Audit Committee and the Board and make a disclosure on the stock exchanges providing a summary of the key observations in the valuation report along with management comments on the same, pursuant to SEBI order dated 24 July 2024.The Valuation Report has come up with valuations of business allegedly foregone and business allegedly gained. Thereafter, the Company has filed an Interlocutory Application (IA) before the Hon'ble Supreme Court of India on 1st April 2026 seeking a direction to SEBI that no steps or actions be taken by the SEBI pursuant to the Valuation Report dated 16th March 2026, including those contemplated in the SEBI order dated 24th July 2024 during the pendency of the Appeal before the Hon'ble Supreme Court. Since then, though the matter has been listed on a few occassions, it could not come up for hearing due to paucity of time. The IA is expected to be listed for hearing shortly. The management is not in a position to estimate the impact of the Valuation Report on the financials of the Company, given that the matter is sub-judice and appeal is pending for hearing before Hon'ble Supreme Court. Management regularly evaluates the business and regulatory risks, including the above matters and it recognizes the related uncertainties around their ultimate outcomes, the impact of which, if any, is not presently ascertainable. (iv) Expenses for the year ended March 31, 2026 are net off Rs 900 millions pursuant to reversal of related liabilities considering change in certain contractual arrangements and related management reassessment. (v) Figures for the last quarter are the balancing figures between audited figures in respect of full financial year upto 31 March 2026 /31 March 2025 and the unaudited published year to date figures upto 31 December 2025/ 31 December 2024 respectively which were subject to limited review. (vi) The Board of Directors of the Company has recommended a total dividend of 120% (i.e., Rs. 12/- per equity share) inclusive of a special dividend of 80% (i.e., Rs.8/- per equity share) on 85,284,223 fully paid-up equity shares of Rs. 10/- each for the year ended 31 March 2026.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 2,07,278.80
Capital work-in-progress 1,34,278.40
Investment property
Goodwill 893.40
Other intangible assets 1,085.00
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 8,202.10
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets
1 Other financial assets 5,724.10
Total of other non-current financial assets 5,724.10
Total non-current financial assets 13,926.20
Deferred tax assets (net)
Other non-current assets
1 Non current tax assets (net) 4,777.80
2 Other non current assets 1,13,436.50
Total of other non-current assets 1,18,214.30
Total non-current assets 4,75,676.10
2 Current assets
Inventories 12,302.30
Current financial asset
Current investments 0.00
Trade receivables, current 50,799.40
Cash and cash equivalents 11,044.60
Bank balance other than cash and cash equivalents 170.40
Loans, current 0.00
Other current financial assets
Total of other current financial assets 2,262.10
Total current financial assets 64,276.50
Current tax assets (net)
Other current assets
1 Other current assets 28,572.70
Total of other current assets 28,572.70
Total current assets 1,05,151.50
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 5,80,827.60
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 8,528.40
Other equity 4,18,126.30
Total equity attributable to owners of parent 4,26,654.70
Non controlling interest
Total equity 4,26,654.70
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease liabilities 7,527.90
Total of other non-current financial liabilities 7,527.90
Total non-current financial liabilities 7,527.90
Provisions, non-current 8,283.70
Deferred tax liabilities (net) 15,027.30
Deferred government grants, Non-current
Other non-current liabilities
1 Other non-current liabilities 1,332.10
Total of other non-current liabilities 1,332.10
Total non-current liabilities 32,171.00
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 7,605.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 49,854.40
Total Trade payable 57,459.40
Other current financial liabilities
1 Lease liabilities 363.70
2 Other financial liabilities 18,157.80
Total of other current financial liabilities 18,521.50
Total current financial liabilities 75,980.90
Other current liabilities 41,359.90
1 Other current liabilities 41,359.90
Total of other current liabilities 41,359.90
Provisions, current 4,299.70
Current tax liabilities (Net) 361.40
Deferred government grants, Current
Total current liabilities 1,22,001.90
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 1,54,172.90
Total equity and liabilites 5,80,827.60
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Unaudited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Gases, related products & services 52,376.50 2,12,818.40
2 Project engineering 22,331.80 98,061.40
3 Share of profit/(loss) from Joint ventures 0.00 0.00
Total Segment Revenue 74,708.30 3,10,879.80
Less: Inter segment revenue 13,275.00 57,815.80
Revenue from operations 61,433.30 2,53,064.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Gases, related products & services 13,180.80 64,188.00
2 Project engineering 1,284.20 11,881.90
3 Share of profit/(loss) from Joint ventures 62.40 5,548.50
Total Profit before tax 14,527.40 81,618.40
i. Finance cost 265.90 1,449.80
ii. Other Unallocable Expenditure net off Unallocable income 2,659.20 6,821.10
Profit before tax 11,602.30 73,347.50
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Gases, related products & services 5,03,178.70 5,03,178.70
2 Project engineering 38,469.70 38,469.70
3 Share of profit/(loss) from Joint ventures 0.00 0.00
Total Segment Asset 5,41,648.40 5,41,648.40
Un-allocable Assets 39,179.20 39,179.20
Net Segment Asset 5,80,827.60 5,80,827.60
4 Segment Liabilities
Segment Liabilities
1 Gases, related products & services 51,013.50 51,013.50
2 Project engineering 65,609.70 65,609.70
3 Share of profit/(loss) from Joint ventures 0.00 0.00
Total Segment Liabilities 1,16,623.20 1,16,623.20
Un-allocable Liabilities 37,549.70 37,549.70
Net Segment Liabilities 1,54,172.90 1,54,172.90
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) Notes: The primary segment for the Company is the Business Segment and it has two such segments which are as follows: a. Gases, related products & services : Comprises manufacture and sale of industrial, medical and special gases as well as related products and services. b. Project Engineering: Comprises sale of cryogenic and non cryogenic air separation plants and projects.



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement gain/(losses) on defined benefit plans 52.20 (154.60)
2 Fair value changes of investments in equity shares (0.40) 0.60
Total Amount of items that will not be reclassified to profit and loss 51.80 (154.00)
2 Income tax relating to items that will not be reclassified to profit or loss (1.00) (38.80)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 52.80 (115.20)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 67,799.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 1,449.80
Adjustments for decrease (increase) in inventories (1,637.90)
Adjustments for decrease (increase) in trade receivables, current (11,982.50)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 4,140.50
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current (4,222.30)
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 2,899.90
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 17,790.30
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 23,487.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 544.90
Adjustments for share-based payments 610.90
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) (89.40)
Other adjustments for non-cash items (768.20)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 31,133.20
Net cash flows from (used in) operations 98,932.20
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 20,381.90
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 78,550.30
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 478.80
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 545.90
Purchase of property, plant and equipment 76,621.90
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 4,902.00
Interest received 221.80
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) investing activities (70,473.40)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 429.70
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 942.30
Dividends paid 10,197.30
Interest paid 0.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (11,569.30)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (3,492.40)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (3,492.40)
Cash and cash equivalents cash flow statement at beginning of period 14,537.10
Cash and cash equivalents cash flow statement at end of period 11,044.70





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Auditor's opinion Qualified opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Price Waterhouse & Co Chartered Accountants LLP Yes 30-11-2026


Financial details

Amount in (Lakhs)

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income 2,54,888.00 2,54,888.00
2 Total Expenditure 1,87,089.00 1,87,089.00
3 Net Profit/(Loss) 54,896.50 54,896.50
4 Earnings Per Share 64.37 64.37
5 Total Assets 5,80,827.60 5,80,827.60
6 Total Liabilities 1,54,172.90 1,54,172.90
7 Net Worth 4,26,654.70 4,26,654.70


Audit qualification

Amount in (Lakhs)

Sr. Details of Audit Qualification Type of Audit Qualification Frequency of qualification For Audit Qualification(s) where the impact is quantified by the auditor For Audit Qualification(s) where the impact is not quantified by the auditor
Management's Views (i) Management's estimation on the impact of audit qualification (ii) If management is unable to estimate the impact, reasons for the same Auditors' Comments on (i) or (ii) above
1 Textual Information(1) Qualified opinion Repetitive Textual Information(2) Textual Information(3) Textual Information(4) Textual Information(5)


Text Block

Textual Information(1) We draw attention to Note (iii)(A) to the consolidated financial results, which explains the Companys Management assessment of related party transactions with reference to the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended (SEBI LODR). Companys Management has applied the materiality threshold of 10% or more of the annual consolidated turnover of the Company to the value of each contract with a related party consisting of individual or multiple transactions and not by aggregating the value of all contracts with each related party to evaluate whether it has breached the materiality threshold and therefore would require shareholders approval as per SEBI LODR. SEBI, in its Order dated July 24, 2024 (the SEBI Order) has concluded that the materiality threshold has to be applied on an aggregate basis considering all the transactions during the financial year with a related party which has also been upheld by the Securities Appellate Tribunal (SAT) vide its order dated December 5, 2025 (the SAT Order). The Companys Management filed an appeal against the SAT Order before the Supreme Court of India, which has been admitted by the Court and the final outcome is awaited. Subsequent to SAT Order, the Company sought the approval of the shareholders in line with the interpretation of SEBI on the materiality threshold of the transactions with a related party, at the Extra-ordinary General Meeting held on March 5, 2026, which, however, shareholders did not approve. In view of aforesaid ongoing regulatory and legal proceedings, the probable consequences and related implications on the consolidated financial results are presently not determinable.
Textual Information(2) Not Applicable as impact has not been quantified.
Textual Information(3) Not ascertainable.
Textual Information(4) Management is not in a position to estimate the impact given that the appeal is pending at Hon'ble Supreme Court of India and the matter is currently sub judice.
Textual Information(5) We draw attention to Note (iii)(A) to the consolidated financial results, which explains the Companys Management assessment of related party transactions with reference to the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended (SEBI LODR). Companys Management has applied the materiality threshold of 10% or more of the annual consolidated turnover of the Company to the value of each contract with a related party consisting of individual or multiple transactions and not by aggregating the value of all contracts with each related party to evaluate whether it has breached the materiality threshold and therefore would require shareholders approval as per SEBI LODR. SEBI, in its Order dated July 24, 2024 (the SEBI Order) has concluded that the materiality threshold has to be applied on an aggregate basis considering all the transactions during the financial year with a related party which has also been upheld by the Securities Appellate Tribunal (SAT) vide its order dated December 5, 2025 (the SAT Order). The Companys Management filed an appeal against the SAT Order before the Supreme Court of India, which has been admitted by the Court and the final outcome is awaited. Subsequent to SAT Order, the Company sought the approval of the shareholders in line with the interpretation of SEBI on the materiality threshold of the transactions with a related party, at the Extra-ordinary General Meeting held on March 5, 2026, which, however, shareholders did not approve. In view of aforesaid ongoing regulatory and legal proceedings, the probable consequences and related implications on the consolidated financial results are presently not determinable.


Signatories detail

Name of CEO / Managing director Milan Sadhukhan
Name of CFO Ajay Kumar Sah
Name of audit committee chairman Subba Rao Amarthaluru
Name of statutory auditor Price Waterhouse & Co Chartered Accountants LLP
Name of other signatory, if any, with designation
Place Bengaluru
Date 30-05-2026